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Non-canonical start codonTMEM16A is a plasma membrane protein with voltage- and calcium-dependent chloride channel activity. The
role of the various TMEM16A domains in expression and function is poorly known. In a previous study, we
found that replacing the ﬁrst ATG of the TMEM16A coding sequence with a nonsense codon (M1X mutation),
to force translation from the second ATG localized at position 117, only had minor functional consequences.
Therefore, we concluded that this region is dispensable for TMEM16A processing and channel activity. We
have now removed the ﬁrst 116 codons from the TMEM16A coding sequence. Surprisingly, the expression of
the resulting mutant, Δ(1–116), resulted in complete loss of activity. We hypothesized that, in the mutant
M1X, translation may start at a position before the second ATG, using a non-canonical start codon. Therefore,
we placed an HA-epitope at position 89 in the M1X mutant. We found, by western blot analysis, that the HA-
epitope can be detected, thus demonstrating that translation starts from an upstream non-ATG codon. We trun-
cated the N-terminus of TMEM16A at different sites while keeping the HA-epitope. We found that stepwise
shortening of TMEM16A caused an in parallel stepwise decrease in TMEM16A expression and function. Our re-
sults indicate that indeed the N-terminus of TMEM16A is important for its activity. The use of an alternative
start codon appears to occur in a naturally-occurring TMEM16A isoform that is particularly expressed in
human testis. Future experiments will need to address the role of normal and alternative amino-terminus in
TMEM16A structure and function.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
The TMEM16A protein (also known as anoctamin-1, ANO1) is a
main component of Ca2+-activated Cl− channels, CaCCs [1–3]. The
transfection of TMEM16A coding sequence in null systems such as
HEK-293 cells generates Ca2+-dependent Cl− currents [1–7]. Converse-
ly, knockdownof endogenous TMEM16Aexpression in airway epithelia,
smooth muscle, salivary glands and other cell types leads to signiﬁcant
reduction of CaCC function [1,3,5,8–11].
Although the detailed structure of TMEM16A protein is unknown,
predictive tools and experimental work suggest the presence of eight
transmembrane domains with the N- and C-termini protruding in the
cytosolic environment. There is uncertainty about the precise localiza-
tion of the ﬁfth and sixth transmembrane domains and the size andS-YFP, halide-sensitive yellow
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. Open access under CC BY-NC-ND licorganization of the connecting region. In one of the studies that de-
scribed the discovery of TMEM16A, this region was proposed as a reen-
trant loop facing the extracellular environment and constituting the
channel pore [3]. In a more recent study, the putative channel pore re-
gion was found to be intracellular [12].
There aremultiple isoforms of TMEM16Aprotein generated by alter-
native splicing or by the use of an alternative promoter [1,13,14]. A
highly basic segment of 22 amino acids, corresponding to exon 6b
may be included/skipped in the cytosolic region preceding the ﬁrst
transmembrane domain. Other two alternative segments of 4 and 26
amino acids, coded by exons 13 and 15, respectively, are localized in
the ﬁrst intracellular loop. For simplicity, these three alternative protein
segments were labeled as b, c, and d [1]. We also found evidence for a
TMEM16A coding sequence (accession no. BC033036) generated by
the use of an alternative promoter. In this case, the ﬁrst two exons, con-
taining the start codon and part of the downstream coding region, were
skipped. The expected result is the translation beginning from the ﬁrst
available ATG codon, localized at position 117 of the normal coding se-
quence.We named the ﬁrst 116 amino acids of TMEM16A as segment a
[1]. The use of the single-letter-labeling of alternative regions allowed a
simple coding of TMEM16A isoforms. For example, TMEM16A(ac) and
TMEM16A(abc) differ by the absence/presence of the 22 amino acids
of segment b (exon 6b). Interestingly, the isoform without segment aense.
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form, named TMEM16A(0), is a functional channel, although with al-
tered voltage-dependence and ion selectivity [15].
In previous studies, replacement of theﬁrst codon of TMEM16A cod-
ing sequence with a nonsense (M1X) or an isoleucine codon (M1I) was
done to force translation from the second methionine at position 117
[15,16]. The expression of these mutants resulted in no change [15], or
a relatively modest change [16], in CaCC properties. Accordingly, we
concluded that the ﬁrst 116 amino acids of TMEM16A protein have a
minor role for function [15].
In the present study, we have reconsidered the role of TMEM16A N-
terminus. We have found evidence for non-canonical translation start
sites. This allows a large part of segment a to be synthesized even in
the absence of an upstream methionine codon. Our experiments show
that the N-terminus of TMEM16A is essential since complete removal
of the ﬁrst 116 amino acid residues abolishes TMEM16A function.
2. Materials and methods
2.1. Cell culture
HEK-293 cellswere cultured inDMEM/Ham's F12(1:1). Themedium
was supplemented with 10% fetal calf serum, 2 mM L-glutamine,
100 U/ml penicillin, and 100 μg/ml streptomycin.
2.2. Generation of TMEM16A mutants
The human TMEM16A(abc) coding sequence was cloned into the
pcDNA 3.1 plasmid as described previously [1]. We introduced a BspEI
restriction enzyme site by mutagenizing a single nucleotide at position
1097 of the TMEM16A(abc) coding sequence. This mutation did not
change the amino acid sequence, nor the extent of protein expression
and activity as shown by functional measurements. To generate the dif-
ferent truncation mutants carrying the triple HA epitope, we used a
strategy based on gene synthesis provided by GenScript (Piscataway,
NJ). The different mutants were generated by synthesizing the desired
DNA fragments ﬂanked at one end by a KpnI site (corresponding to
the one present in the vector polylinker) and at the other end by the
BspEI site. These fragments were cut and pasted into the wild type
TMEM16A sequence. To generate the BC033036 construct with the tri-
ple HA-epitope, a larger fragment was synthesized, ﬂanked by the
KpnI site and an EcoRI site localized at position 1836 in the TMEM16A
coding sequence. Further details may be provided on request. Single
amino acid mutants were generated using the QuikChange XL site-
directed mutagenesis kit (Stratagene). All mutants were checked by
DNA sequencing.
2.3. Transient transfections
For the functional assay based on the halide-sensitive yellow ﬂuo-
rescent protein (HS-YFP), HEK-293 cells were seeded in 96-well
microplates (25,000 cells/well) in 100 μl of antibiotic-free culturemedi-
um. After 6 h, cells were co-transfected with plasmids carrying the cod-
ing sequence for TMEM16A constructs and the YFP-H148Q/I152L [17].
For each well, 0.2 μg of total plasmid DNA and 0.5 μl of Lipofectamine
2000 (Life Technologies) were ﬁrst pre-mixed in 50 μl of OPTI-MEM
(Life Technologies) to generate transfection complexes (60 min at
room temperature), and then added to the cells. After 24 h, the com-
plexes were removed by replacement with fresh culture medium plus
antibiotics. TheHS-YFP functional assaywas performed48 h after trans-
fection. For patch-clamp experiments, 500,000 HEK-293 cells in 1.5 ml
culture medium without antibiotics were mixed with 0.5 ml of
OPTIMEM containing 2 μg of plasmid DNA and 5 μl of Lipofectamine
2000 (previously incubated for 60 min at room temperature to allow
formation of lipid/DNA complexes). Cell suspension was then plated
as 5–6 drops in the center of 35 mm Petri dishes. After 5–6 h, eachPetri dish received 2 ml of culture medium without antibiotics. After
24 h, the complexes were removed by replacement with fresh culture
medium plus antibiotics. Patch-clamp experiments were carried out
2–3 days after transfection.
2.4. HS-YFP assay
Transfected HEK-293 cells were washed two times with 100 μl of
PBS (137 mM NaCl, 2.7 mM KCl, 8.1 mM Na2HPO4, 1.5 mM KH2PO4,
1 mM CaCl2, and 0.5 mM MgCl2; pH = 7.4) and incubated for 30 min
with 60 μl of PBS. After incubation cells were transferred to amicroplate
reader (FluoStar Galaxy; BMG Labtech, Ortenberg, Germany) for CaCC
activity determination. The plate reader was equipped with high-
quality excitation (ET500/20×) and emission (ET535/30 m) ﬁlters for
YFP (Chroma Technology Corp., Brattleboro, VT, USA). Each assay
consisted of a continuous 14 s ﬂuorescence reading with 2 s before
and 12 s after injection of 165 μl of modiﬁed PBS (Cl− replaced by l−
ﬁnal l− concentration in the well: 100 mM) also containing 1 μM
ionomycin. Data were normalized to the initial, background-
subtracted, ﬂuorescence. To determine ﬂuorescence quenching rate
(QR) associated with l− inﬂux, the ﬁnal 11 s of the data for each well
were ﬁtted with an exponential function to extrapolate the initial
slope (dF/dt).
2.5. Western blots
HEK-293 cells were grown to subconﬂuence on 60 mm-diameter
dishes. To express the different TMEM16A protein constructs, cells
were transiently transfected using 10 μl of Lipofectamine 2000 and
4 μg of mammalian expression plasmids pcDNA 3.1 carrying the coding
sequence for TMEM16A or the HS-YFP. Cells were lysed in RIPA buffer
1× (50 mM Tris–HCl pH 7.4, 150 mMNaCl, 1% Triton X-100, 0.5% sodi-
um deoxycholate, 0.1% SDS) containing Complete Protease Inhibitor
Cocktail (Roche, NJ, USA). The protein concentration in lysates was
quantiﬁed using the Quantum Protein Assay kit (Euroclone). Total ly-
sates were electrophoresed (30 μg per lane) with NuPAGE Novex Bis-
Tris 4–12% gel (Life Technologies) and transferred to a nitrocellulose
membrane (Bio-Rad, Hercules, CA, USA) for Western blotting.
The TMEM16A protein was immunodetected with the rabbit SP31
monoclonal antibody (Abcam; 1:1000). TMEM16A proteins tagged
with the HA-epitope were also detected with the mouse HA.11 clone
16B12 monoclonal antibody (Covance; 1:1000). Secondary antibodies
were anti-rabbit or anti-mouse HRP (Millipore; 1:5000 and 1:10,000,
respectively). Membranes were also stripped with the RestoreWestern
Blot Stripping Buffer (Thermo Fisher Scientiﬁc Inc.) and incubated with
anti-actin goat polyclonal I19 antibody (Santa Cruz Biotechnology)
followed by anti-goat HRP-conjugated secondary antibody (Santa Cruz
Biotechnology). All antibodies were dissolved in 5% skimmed-milk in
Tris-buffered saline–Tween 20. Protein bands were visualized using
the ECL Advanced Western Blotting Detection Kit (GE Healthcare
Europe, Little Chalfont, UK). Direct recording of the chemiluminescence
was performed using theMolecular Imager ChemiDoc XRS System (Bio-
Rad). Densitometry analysis of bands was done with the ImageJ
software.
2.6. Patch-clamp experiments
Whole-cell membrane currents were recorded in HEK-293 tran-
siently transfected cells. The extracellular solution had the following
composition: 150 mMNaCl, 1 mMCaCl2, 1 mMMgCl2, 10 mMglucose,
10 mM mannitol, and 10 mM Na-HEPES (pH = 7.4). The pipette (in-
tracellular) solution contained: 130 mM CsCl, 10 mM EGTA, 1 mM
MgCl2, 10 mMCs-HEPES (pH = 7.35), and 1 mMATP, plus CaCl2 to ob-
tain the desired free Ca2+ concentration: 1 mM for 8 nM, 8 mM for
305 nM, 9 mM for 685 nM, and 9.5 mM for 1.44 μM (calculated with
a dissociation constant for the EGTA-calcium complex of 76 nM at
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ries resistance were analogically compensated using the circuitry pro-
vided by the EPC7 patch-clamp ampliﬁer. The stimulation protocol to
generate current–voltage relationships consisted in 600 ms-long volt-
age steps from−100 to +100 mV in 20 mV increments starting from
a holding potential of −60 mV. The waiting time between steps was
4 s. Membrane currents were ﬁltered at 1 kHz and digitized at 5 kHz
with an ITC-16 (Instrutech) AD/DA converter. Data were analyzed
using the Igor software (Wavemetrics) supplemented by custom soft-
ware kindly provided by Dr. Oscar Moran (Institute of Biophysics,
CNR, Genova).2.7. RT-PCR
Onemicrogram of total RNA derived from 18 different human tissues
(HumanTotal RNAMaster panel II, Clontech)was retro-transcribed using
IScript RT kit (Biorad) and subsequently ampliﬁed by PCR.
PCR conditions for the normal 5′-end of TMEM16A and for beta-2
microglobulinwere: initial denaturation at 95 °C for 5 min for the initial
denaturation; 30 cycles of 95 °C for 30 s, 60 °C for 30 s, and 72 °C for
40 s; ﬁnal extension at 72 °C for 7 min. PCR conditions for the alterna-
tive 5′-end of TMEM16A were: initial denaturation at 95 °C for 5 min;
30 cycles of 95 °C for 30 s, 63 °C for 30 s, and 72 °C for 40 s;ﬁnal exten-
sion at 72 °C for 7 min.
We used the following forward and reverse primers for the normal
TMEM16A 5′-end: 5′-GGCGGTCCCAGCGCACAG and 5′-CCGGTTGCC
CGAGGGCC. For the alternative TMEM16A 5′-end the primers were:
5′-GCCGGCACCAAATGCTGACCA and 5′-CCGGTTGCCCGAGGGCC. For
beta-2 microglobulin, the primers were: 5′-GCGCTACTCTCTCTTTCTGG
and 5′-GATGCCGCATTTGGATTGGA.Fig. 1. Analysis of TMEM16A translation start site. A) TMEM16A topology and amino acid seque
clone BC033036 is shown as an inset. White triangles and the black triangle show sites where t
iments reported in Fig. 3). B) Electrophoreticmobility ofwild type andmutant TMEM16A prote
ATG was replaced with a nonsense (M1X) or an isoleucine (M1I) codon. A double mutant with
dicated, cell lysates were treated with PNGaseF to remove sugars. Densitometric analysis of TM
band in each sample was normalized to the expression of actin and then to the expression of w
ples). C) Activity of wild type andmutant TMEM16Adeterminedwith theHS-YFP assay. Activity
p b 0.001 vs. mock-transfected cells; n = 5–6).The ampliﬁed products (260 bp for normal TMEM16A; 286 bp for
the alternative TMEM16A, and 371 bp for beta-2 microglobulin) were
resolved on 1.5% agarose gels. The identity of bands detected in testis
and lung were veriﬁed by sequencing.
2.8. Statistics
Data are presented as representative traces/images or as mean ±
SEM. Statistical analysis was done with the InStat software (GraphPad).
Signiﬁcant differences between data were calculated with the Student's
t test.
3. Results
The region of the TMEM16A protein preceding the ﬁrst transmem-
brane domain is composed of nearly 330 amino acids. We previously
found evidence for an isoform lacking the ﬁrst part of this region [1]. In-
deed, a cDNA clone (BC033036) contained a different 5′ sequence, as
shown in Fig. 1A. Due to the use of an alternative promoter, the tran-
scription of the ﬁrst two exons is skipped and another sequence is
added at the beginning of the transcript. The consequence is the re-
placement of the ﬁrst 36 codons with a sequence lacking an ATG (and
carrying three non sense codons in framewith the downstream region).
The expected result is that the beginning of translation will occur at the
next available ATG codon, at position 117 of full length TMEM16A cod-
ing region (Fig. 1A). The inspection of the sequences surrounding the
two ATGs at position 1 and 117 reveals that the ﬁrst onemay be favored
as a translation start site. The general Kozak consensus indicates a pu-
rine (A or G) at position−3 and a G at position +4 as preferred nucle-
otides [18]. The ﬁrst ATG in the TMEM16A coding sequence has thence of the TMEM16A amino-terminus. The alternative 5′-untranslated region of the cDNA
he stop codonmutations and the HA epitope were introduced, respectively (for the exper-
ins as detected inwestern blot experiments (with anti-TMEM16A SP31 antibody). The ﬁrst
methionines 1 and 117 replaced by isoleucine was also studied (M1I-M117I). Where in-
EM16A expression from four experiments is shown in the bar graph. The intensity of the
ild type TMEM16A (white bar for glycosylated samples, gray bar for deglycosylated sam-
, reported as quenching rate (QR), was determinedwith andwithout 1 μM ionomycin (***,
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+4. However, the ﬁrst ATGmay be preferred because it is ﬁrst encoun-
tered by the ribosome during the scanning of the mRNA and because
AxxATGA is more probable as a translation start site than CxxATGG
[18]. Furthermore, a G at position −6, present before the ﬁrst and not
the second ATG, seems to be also important. In the absence of the ﬁrst
ATG, as in the BC033036 transcript, translation should start at methio-
nine 117.
In our previous study, the isoform corresponding to cDNA clone
BC033036 was named TMEM16A(0) because it appeared to lack the
116 amino acids of segment a as well as the other alternative segments
b, c, and d [1].
We previously replaced the ﬁrst ATG with a stop codon (mutant
M1X) in order to force the beginning of translation at the second ATG
thus skipping segment a [15]. In another study, a similar experiment
was carried out by changing the ﬁrst ATG with ATC, i.e. an isoleucine
codon [16]. In the ﬁrst study, M1X generated Cl− currents very similar
to those of the wild type protein [15]. In the second study, M1I,
named Δ1,2(5′), also generated Cl− currents but with slightly slower
activation at positive membrane potentials [16]. For the present study,
we investigated the electrophoretic mobility of proteins lacking the
ﬁrst ATG. Surprisingly, we found that these mutant proteins migrate
in the gelwith an apparentmolecular size (120 kDa) similar, if not iden-
tical, to that of thewild type protein (Fig. 1B). In contrast tomobility, the
expression level appeared to be reduced by replacement of the ﬁrst
methionine.
The electrophoretic mobility of mature TMEM16A protein as a dif-
fuse band is due to glycosylation. To generate protein bands with a
sharper aspect and amore deﬁnedmolecularweight, we deglycosylated
TMEM16A protein with PNGaseF. With this treatment, the relative mo-
bility of M1X and M1I with respect to wild type TMEM16A did notFig. 2. Role of segment a in TMEM16A N-terminus. A) Activity of wild type and mutant protein
mock-transfected cells; n = 5–6). B) Electrophoretic mobility of a TMEM16A protein lacking th
shows densitometric analysis to estimate TMEM16A protein expression. In each sample, the in
sponding band of wild type TMEM16A. For experiments with Δ(1–116) and without PNGaseF
samples. Data (mean ± SEM) are from four experiments. C) Representative membrane curren
elicited by voltage steps in the−100 to+100 mV range. Cytosolic free Ca2+ concentrationwas
weremeasured at the end of voltage pulses. Each point is themean ± SEM from 6–9 experimen
initial current (I0), the activation time constant (τact), and the deactivation time constant (τdeachange (Fig. 1B). The three proteins appeared to have essentially the
same electrophoretic mobility (~100 kDa) although having a calculated
molecular weight difference of ~12 kDa (mutant vs. wild type protein).
Although relatively small, this difference should be visible in the gel. For
comparison, we found that a TMEM16A protein lacking the last 44
amino acids at the C-terminus (theoretical loss of ~4.5 kDa) ran signif-
icantly faster in the gel electrophoresis (not shown). We also studied a
third variant which was generated by mutating both M1 and M117 to
ATC [16]. In this way, translation should start at methionine 176 thus
resulting in the lack of the amino acids coded by exons 1–3 (mutant
Δ1,2,3(5′)). Strikingly, the Δ1,2,3(5′) mutant (i.e. M1I-M117I) had the
same electrophoretic mobility of the wild type, M1X, and M1I proteins
(Fig. 1B). To assess the ion channel function of N-terminal variants, we
used the assay based on the halide-sensitive yellow ﬂuorescent proteins
(HS-YFP). This assay measures the rate of HS-YFP ﬂuorescence
quenching (QR) caused by I− inﬂux through TMEM16A channels. As
shown in Fig. 1C, the proteins lacking the ATG codons at the N-
terminus were functional with a rate of halide transport smaller than
that of the wild type protein but still several folds larger than that of
mock-transfected cells. Due to the intriguing results regarding the mo-
bility of TMEM16A proteins lacking the ﬁrst methionine, we
reconsidered the issue of TMEM16A N-terminus.
The ﬁrst hypothesis that we formulated was that the translation of
wild type TMEM16A protein does not start from the ﬁrst or the second
ATG, as considered before, but from a downstream codon. Therefore,
mutagenesis of ATGs at position 1 and 117 should not affect the protein
expression and function. This hypothesis was disproved by two types of
experiments. We generated a TMEM16A construct with both ATGs
mutagenized to stop codons (M1X-M117X). This construct was not
functional (Fig. 2A). We also generated a construct, named Δ(1–116)-
TMEM16A, entirely lacking the 116 codons of segment a. This constructs determined with the HS-YFP assay and reported as quenching rate, QR (***, p b 0.001 vs.
e ﬁrst 116 codons, Δ(1–116), compared to the wild type andM1X proteins. The bar graph
tensity of the band was normalized to actin expression and then to intensity of the corre-
we considered the top band. White bars: glycosylated samples. Gray bars: deglycosylated
ts from patch-clamp experiments. The three panels of traces show superimposed currents
685 nM. D) Current–voltage relationships from experiments as those shown in C. Currents
ts. E) Comparison ofwild type andM1X-TMEM16A. The bar graphs report the normalized
ct) using the voltage pulse to +100 mV.
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western blot experiments, the Δ(1–116)-TMEM16A protein showed
a markedly smaller size compared to M1X-TMEM16A (80 vs.
100 kDa in deglycosylated samples) as evident from the faster elec-
trophoretic mobility (Fig. 2B). We compared the properties of mem-
brane currents generated by expression of wild type and M1X-
TMEM16A (Fig. 2C–E). The amplitude of the currents at different
membrane potentials was similar (Fig. 2D), as well as the activation/
deactivation kinetics (Fig. 2E).We also calculated the normalized initial
current (I0), i.e. the current measured at the beginning of the voltage
pulse divided by total current. This value was also similar in the wild
type and mutated construct (Fig. 2E). Summarizing, M1X and Δ(1–
116) constructs generate completely different results although having
in common the TMEM16A coding sequence beginning with codon
117. M1X-dependent channels have wild type characteristics whereas
the Δ(1–116) construct is non functional (Fig. 2C,D).
To explain these results, we formulated a second hypothesis based on
increasing evidence from the literature about the use of non-canonical
codons to start translation [19–23]. We postulated that, in the absence
of the ﬁrst ATG (as in M1X andM1I), translation may start from another
type of codon present in the ﬁrst part of segment a. According to the lit-
erature, the most probable candidates are CTG and GTG, corresponding
to leucine and valine. As shown in Fig. 1A, there are multiples CTG and
GTG codons at the beginning of TMEM16A coding sequence. In particu-
lar, some of them, like the CTG codons present at positions 31 and 37,
have a signiﬁcant probability of being translation start sites accordingFig. 3. Effect of progressive N-terminus truncation. A) Schematic representation of the various t
HA epitope, and possible (alternative) translation start sites is shown. Additional information a
construct indicates the presence of the alternative 5′-endwhich contains three stop codons in fr
for the various constructs using the HS-YFP assay (** and ***, p b 0.01 and p b 0.001, respective
(TMEM16A(0)), and truncationmutants. All proteinswere tagged and detected using the HA ep
actin expression (n = 6). For this analysis, we considered the intensity of the band with the hig
lysates from R56X-transfected cells were treated with/without PNGaseF. D) Normalized TMEM
TMEM16A protein expression.to the surrounding sequence. For example, both sites show a G and a C
at positions -6 and -4, respectively, which are frequently seen in other
proteins with noncanonical translation codons [21].
To test the existence of alternative start codons in TMEM16A, we
generated several constructs each one carrying a stop codon mutation
at different positions within segment a (Fig. 3A). In addition, the se-
quence upstream of each stop codon was removed. All constructs had
also a triple hemagglutinin (HA) epitope between threonine 88 and
proline 89 to allow efﬁcient protein detection. The different constructs
were analyzed at the functional level with the HS-YFP assay (Fig. 3B).
The removal of ﬁrst ATG in the M1X mutant or removal of the ﬁrst 16
codons (S16X) caused a similar 40% decrease in activity. Further trunca-
tion of the N-terminus (L31X and S33X), resulted in lower but signiﬁ-
cant levels of activity relative to mock transfected cells (Fig. 3B). The
complete loss of halide transport was instead observed for S74X.
These constructs were also analyzed in western blot experiments. Im-
portantly, the expression of theM1X construct generated a clear protein
band recognized by the anti-HA antibody (Fig. 3C). Since there are no
ATGs upstream in the region before theHA sequence, this result demon-
strates that translation occurs from a non-canonical start codon. Al-
though the M1X band had a lower intensity with respect to the wild
type TMEM16A band, it had similar electrophoretic mobility corre-
sponding to ~120 kDa. The constructs S16X, L31X, S33X, and R56X
were also detected by the anti-HA antibody as bands of similar size.
However, R56X also showed expression of a second band (~100 kDa)
probably corresponding to a partially glycosylated form of the protein.runcationmutants used in the study. The position of the twomethionines (1 and 117), the
bout the constructs is also depicted in Fig. 1A. The dashed line reported for the BC033036
amewith the downstream coding sequence. B) Ca2+-activated halide transportmeasured
ly, vs. mock-transfected cells; n = 6). C) Electrophoretic mobility for wild type, BC033036
itope. The bar graph shows the densitometric analysis of TMEM16A protein normalized to
hest molecular weight. The inset on the right shows results from an experiment in which
16A activity. Anion transport activity (QR) from HS-YFP experiments was normalized to
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gle band of lower molecular weight (Fig. 3C, inset). The expression of
the S74X mutant resulted in a weak band of less than 90 kDa
(Fig. 3C). Summarizing, progressive truncation of 5′-coding region of
TMEM16A results in almost unaltered electrophoretic mobility when
the affected region is included between codons 1 and 56. Further down-
stream truncation results in signiﬁcant shortening of the protein detected
by western blot experiments. Regarding protein expression levels, a ﬁrst
drop occurs for M1X and S16X. A second drop occurs for mutants L31X
and S33X. Finally, a more marked loss in expression occurs by truncation
at codon 56. We normalized the activity of the different TMEM16A con-
structs, measured with the HS-YFP assay, to the protein expression level
(Fig. 3D). After normalization, the activity of the various truncated ver-
sions of TMEM16A (except for S74X) was comparable to that of the
wild type protein. This result suggests that the decrease in activity caused
by progressive shortening of the N-terminus is due to a decrease in pro-
tein expression rather than to an impairment in intrinsic channel activity.
We carried out a series of control experiments to check the validity
of our conclusions. First, we veriﬁed that the stop codon introduced at
the beginning of our constructs was indeed preventing the translation
from upstream sites. To do so, we placed the 3XHA epitope right before
the M1X mutation, without other codons in between (Fig. 4A). The ex-
pression of this construct (HA-M1X) generated a protein that, as
expected, was detected by the anti-TMEM16A (SP31) antibody but
not by the anti-HA antibody (Fig. 4A). This ﬁnding demonstrates that
the results shown in Fig. 3 are not affected by a combination of events
that involve: i) start of translation from a codon localized further up-
stream in the plasmid; ii) readthrough of the stop codon introduced at
the beginning of TMEM16A coding sequence. We also checked that
the anti-HA antibodywas unable to detect the untagged TMEM16Apro-
tein (Fig. 4B).Fig. 4. Western blot analysis of TMEM16A protein constructs with anti-TMEM16A and
anti-HA antibodies. A) Results show that anti-HA detects the proteinwhen theHA epitope
is placed after (M1X-HA, S16X-HA) and not before (HA-M1X) the stop codon. B) The anti-
HA antibody does not react with the wild type TMEM16A protein.Patch-clamp experiments were also carried out to analyze the func-
tional properties of truncated TMEM16A constructs (Fig. 5). The removal
of the ﬁrst ATG with the M1X mutation did not cause a signiﬁcant de-
crease in activity. Actually, cells expressing M1X-TMEM16A displayed
large CaCC currents indistinguishable from those elicited by wild type
TMEM16A (Fig. 5). In particular, with an intracellular Ca2+ concentration
of 685 nM, the currents elicited by expression of the wild type and mu-
tant protein were similarly activated when the membrane potential
was turned fromholding (−60 mV) to positive values. Large tail currents
were observed at the end of the voltage step. Membrane currents with
similar aspect, although of smaller amplitude, were also observed with
the expression of S16X, L31X, and S33X mutants. We compared the nor-
malized initial current (I0) among the different constructs. This valuewas
signiﬁcantly higher in L31X, S33X, and R56X relative to wild type protein
(Fig. 5B). This result indicates that the fraction of the total current that is
activated by membrane depolarization is decreased by progressive trun-
cation of the N-terminus. Regarding kinetics, the time constants of cur-
rent activation were all similar to each other, as already shown for wild
type and M1X (Fig. 2E). Instead, a signiﬁcant increase (p b 0.05) in the
time constant of current deactivation was seen for S16X (139 ± 4 ms),
L31X (108 ± 9 ms), and S33X (115 ± 16 ms) compared to wild type
TMEM16A (75 ± 6 ms) (not shown). Cells transfected with S74X-
TMEM16A were instead devoid of signiﬁcant CaCC channel activity
(Fig. 5A), a result consistent with the results from the HS-YFP assay
(Fig. 3B).
We asked whether the decrease in the amplitude of membrane cur-
rents found for themutants with the largest truncation, such as R56X, is
due to an alteration in Ca2+ sensitivity. Therefore, we measured cur-
rents at various cytosolic Ca2+ concentrations. These experiments
showed a modest shift in the Ca2+-dependence for R56X-TMEM16A
compared to thewild type protein. Indeed, the half effective concentra-
tions were 490 and 340 nM, respectively (Fig. 5C). This result indicates
that themarked decrease in anion transport caused by truncation of the
N-terminus is mainly due to a decrease in protein expression.
We also studied the isoform corresponding to the BC033036 cDNA
clone, that we previously named TMEM16A(0). Our previous interpre-
tation was that the protein corresponding to this cDNA clone is devoid
of the ﬁrst 116 amino acids because of the lack of the ﬁrst ATG codon
[1]. However, because of our ﬁndings with the Δ(1–116) mutant, we
performed experiments in which the BC033036 sequence was tagged
with the 3XHA epitope in the same position of the other constructs (be-
tween codons 88 and 89; Fig. 3A). Interestingly, in immunoblotting ex-
periments, we detected a band using the anti-HA antibody (Fig. 3C).
This clearly indicates that the translation starts from a non-ATG codon
also in this construct. At the functional level, we found that the HA-
tagged BC033036 is signiﬁcantly functional although less than the
wild type protein. In the HS-YFP assay, the rate of halide transport was
7-fold larger than that of mock-transfected cells (Fig. 3B). In patch-
clamp recordings, the expression of BC033036 was associated with sig-
niﬁcant membrane currents compared to mock-transfected cells
(Fig. 5A). Similarly to other mutants with comparable level of trunca-
tion, such as L31X and S33X, BC033036 had reduced activation at posi-
tive membrane potentials compared to currents elicited by the
expression of wild type protein (Fig. 5B). Interestingly, the currents of
BC033036 had amoremarked voltage-dependent component than pre-
viously observed [15].
We evaluated various human tissues looking for the expression of
the alternative 5′-end. For this purpose, we used two separate RT-
PCRs: one reaction to detect the regular TMEM16A 5′-end and the
other reaction for the alternative end. Regular TMEM16Awas expressed
in lung, prostate, salivary gland, placenta, and, to a lower level, in testis,
kidney, liver, skeletal muscle, heart, and thyroid (Fig. 6). In contrast, the
alternative 5′-end was expressed only in testis and, more weakly, in
lung. The ampliﬁcation products were sequenced to conﬁrm their iden-
tity. Sequencing demonstrated that the BC033036 5′-end was indeed
expressed in testis.
Fig. 5. Functional analysis of TMEM16A truncationmutants. A) Representativemembrane currents (left) and current–voltage relationships (right). measured in HEK-293 cells transfected
with the indicated constructs. Cytosolic free Ca2+ concentration was 685 nM. B) Normalized initial current (I0) measured at +100 mV for the various constructs (* and **, p b 0.05 and
p b 0.01, respectively, vs. wild type; n = 3–9). C) Ca2+-dependence of wild type and R56X-TMEM16A. Themembrane conductance in each experiment was calculated from the tail cur-
rent elicited at−60 mV following the pulse at+100 mV. The normalized conductance (G/Gmax)was then plotted vs. the cytosolic free Ca2+ concentration. Each point is themean ± SEM
of 5 experiments. Data were ﬁtted with the Hill equation.
Fig. 6. Tissue expression of TMEM16Awith normal and alternative 5′-end. RT-PCRwas done on RNA extracted for indicated humanorgans. The expression ofβ2-microglobulin (β2m)was
also determined for control. Data are representative of three similar experiments.
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TMEM16A is a member of a novel family of membrane proteins
which play a variety of physiological functions linked to ion transport.
TMEM16 proteins probably share a series of structural features includ-
ing the overall topology, consisting of eight transmembrane domains.
The region between the sixth and the seventh transmembrane domain
may be particularly important for the regulation of protein activity by
cytosolic Ca2+. In particular, two glutamic acid residues are probably in-
volved in direct Ca2+ binding, at least in TMEM16A and TMEM16F
[12,24]. The ﬁrst intracellular loop is also involved in the regulation of
TMEM16A channel activity by Ca2+ and membrane potential [7,13].
The role of the other protein domains is unclear.
In previous studies, we introduced mutations in the ﬁrst ATG of the
coding sequence in order to force the translation from the second ATG
thus skipping the ﬁrst 116 amino acid residues [15,16]. This interven-
tion resulted in no change or in a relatively minor modiﬁcation of
TMEM16A channel kinetics. Such results indicated that the ﬁrst part of
the N-terminus may be removed without a dramatic loss in channel
function. However, as demonstrated in the present study, the previous
experiments were affected by the unexpected involvement of non-
canonical translation start codons. Indeed, by analyzing the electropho-
reticmobility, we have now found that themutants lacking theﬁrstme-
thionine codon have an apparent size comparable to that of the wild
protein despite a theoretical loss of nearly 12 kDa. To explain this ﬁnd-
ing, we initially considered the possibility that the translation of
TMEM16A protein actually starts always from the second ATG, at posi-
tion 117. This would explain the similarity in molecular size and func-
tion between wild type and mutant proteins. However, this
hypothesis was disproved by removing the entire coding sequence cor-
responding to the ﬁrst 116 codons. In this case, the activity was totally
lost. This result also indicated that translation does not start from a
third downstream methionine codon. Therefore, we considered the
possibility of a translation start from a non-ATG codon. This hypothesis
was supported by the increasing evidence that translation of proteins
may actually start from other codons, in particular from CTG and GTG
[19–23]. In a recent study, global analysis of protein translation by ribo-
some proﬁling revealed an unexpected large use in cells of alternative
codons, particularly of CTG [20]. Therefore, we generated a series of con-
structs in which we removed the ﬁrst methionine and progressively
shortened the downstream coding sequence. The translation start
from a noncanonical codon was demonstrated by using an HA epitope
placed before the second methionine. By using this approach, we
found that M1X and the other mutant proteins lacking the ﬁrst methio-
ninewere detected by the anti-HA antibody. Furthermore,most of these
proteins had a size close to that of the wild protein. Regarding protein
expression level, a ﬁrst drop was observed for mutants M1X and S16X.
A second was instead found for L31X and S33X. Therefore, progressive
truncation of the N-terminus resulted in a stepwise decrease and not
in a sharp loss of expression and function at a single site of protein se-
quence. These results suggest that more than one alternative start
codon may be used. The precise identity of these codons is not certain.
However,we postulate twomainCTG codons at position 31 and 37. Leu-
cine 31 could be used in the case of mutants M1X and S16X. Leucine 37
could be instead the start codon for mutants L31X and S33X. Other
downstream non canonical codons must be used for mutants R56X
and S74X. In particular, S74X is still recognized by the anti-HA antibody
but the size of the resulting TMEM16A protein appears signiﬁcantly
shortened.
Our ﬁndings are relevant to the amino acid composition of the
TMEM16A(0) isoform (i.e. BC033036 clone). We previously concluded
that, by lacking the ﬁrst methionine codon, this protein was also devoid
of the ﬁrst 116 amino acids [1]. Instead, our present results indicate that
the TMEM16A(0) protein has additional amino acids at the N-terminus.
This has been demonstrated by ﬁnding that the HA epitope, placed in a
site that was considered part of the 5′-untranslated region, was actuallyincluded in the protein. As shown in Fig. 1A, the start codon for the
TMEM16A(0) isoform could be leucine 37. If so, this isoform would
have 80 additional amino acids at the N-terminus, a feature that could
be important for the protein function. Indeed, without this region, as
in the case of the Δ(1–116) mutant, the protein is totally inactive.
Using RT-PCR, we have determined the expression among different
human organs of the RNA sequence corresponding to the alternative
N-terminus . The skipping of the ﬁrst two exons appears as an infre-
quent event, identiﬁed only in testis and lung. The particular expression
of this alternative form in testis is not surprising for various reasons. Ac-
tually, the BC033036 clone, that was initially identiﬁed as the one cod-
ing for TMEM16A(0) isoform, was derived from a testis cDNA library
[1]. In addition, a search using BLAST alignment reveals that many
ESTs from testis have the alternative end. This ﬁnding is consistent
with various reports showing that in testis, for reasons that are still
unknown, the expression of many genes is affected by the use of alter-
native transcription and translation start sites [19,25–28]. This phenom-
enon may be related to the particular processes associated with sperm
cell development and function [29]. Interestingly, human spermatozoa
have been shown to possess a Ca2+-dependent Cl− channel, a kind of
activity that could be attributed to TMEM16A expression. Indeed, the
use of a TMEM16A inhibitor signiﬁcantly reduced acrosome reaction
in spermatozoa [30].
Our results are also relevant to the ﬁndings obtained in patientswith
diabetic gastroparesis [16]. In these patients, an abnormal TMEM16A
transcript was found, characterized by the loss of the ﬁrst three exons,
i.e. Δ1,2,3(5′). The conclusion in the previous study was that the
resulting proteinwould have altered channel gating properties. Howev-
er, as discussed in the introduction, this conclusion derived from the
mutagenesis of the methionines in position 1 and 117 [16]. We now
know that the results from these experimentswere affected by the pres-
ence of alternative translation start sites and that the TMEM16A isoform
generated by the skipping of the ﬁrst three exons is actually totally de-
void of activity. This indicates that the function of interstitial cells of
Cajal (ICCs) in diabetic patients would be more severely impaired than
previously expected. A drastic decrease in TMEM16A function, causing
the loss of chloride conductance and excitability of ICCs, would explain
the gastroparesis.
Summarizing, our study have several important implications. First,
in contrast to previous conclusions, the initial part of the TMEM16A N-
terminus has an important role in protein expression and function. Sec-
ond, TMEM16A is another of the many proteins that are affected by
translation from noncanonical start sites. The physiological meaning of
this phenomenon is unclear but may be important when alternative
promoters are activated as in testis.
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